1. Introduction {#sec0005}
===============

Coronary artery disease (CAD) and acute coronary syndromes (ACS) are a leading cause of death all around the globe. The introduction of new pharmacological therapeutics along with a steady reduction in coronary revascularization delays throughout the last two decades has led to substantial improvements in both short- and long-term prognoses.[@bib0090], [@bib0095], [@bib0100] In Western countries, where efficient primary percutaneous coronary intervention (pPCI) programs have been implemented, in-hospital mortality in patients presenting with ST-segment elevation myocardial infarction (STEMI) has decreased in a striking manner and throughout all age categories.[@bib0090] On the other hand, in developing countries, and especially with the progressive adoption of westernized lifestyles and the increase of life expectancy, CAD is more frequently encountered in older age groups and patients presenting with STEMI in healthcare structures have a changing epidemiology and outcomes over time. Published data from Middle East and North Africa addressing the in-hospital prognosis of STEMI specifically in the elderly are scarce. Available data put the emphasis on the changing risk profile in this region of the world and often seek to compare patients' characteristics and STEMI prognosis with that in Western series in a general manner.[@bib0105], [@bib0110] Studies from North African countries addressing the specific issue of CAD in the elderly are nearly absent.

Therefore in this study, we sought to determine in-hospital outcomes for elderly patients presenting with STEMI in a Tunisian center and to study factors related to in-hospital death in this population.

2. Methods {#sec0010}
==========

2.1. Study population and design {#sec0015}
--------------------------------

The analyses were performed on data from the STEMI registry of the cardiology B department of Fattouma Bourguiba University Hospital (Monastir, Tunisia). The registry includes retrospectively all consecutive patients presenting to our center via the emergency department or the *SAMU* (*Service d'Aide Médicale Urgente* for Emergency Medical Service) and for whom the final diagnosis established was STEMI, regardless to the therapeutic strategy implemented. The diagnosis of STEMI was established in the presence of 2 mm (in precordial leads) or 1 mm (in frontal leads) ST-segment elevation in two adjacent leads or a new left bundle branch block concurrently to a typical prolonged chest pain (\>20 min). The registry is updated for new patients and outcomes in a yearly fashion.

The present study included patients enrolled during the period between January 1998 and January 2013. The overall study population was divided into two groups according to age; patients, who were ≥75 years old, were considered elderly. Demographic features, cardiovascular risk factors, clinical presentation, and in-hospital course were compared between the two study groups. Given the relatively small number of patients in the two age sub-groups, temporal trends for reperfusion therapy and in-hospital mortality were reported for the four four-year sub-periods of the study (1998--2001, 2002--2005, 2006--2009 and 2010--2013). Anemia was defined as a hemoglobin rate \<12 g/dL in men and \<11 g/dL in women. Heart failure on-admission was defined as a Killip class II or III upon presentation. Renal failure on-admission was defined as a creatinine clearance \<45 mL/min using the Modification of Diet in Renal Disease (MDRD) formula in patients not previously known to suffer from chronic kidney disease (CKD); in patients known to have CKD, renal failure on-admission was defined as an increase of ≥30% of baseline serum creatinine rate. Patients on dialysis were excluded. All patients received 100 IU per kg of weight of unfractionated heparin upon diagnosis, 250 mg aspirin and a loading dose of 300 or 600 mg clopidogrel according to the reperfusion strategy chosen (thrombolysis or pPCI). If no reperfusion modality was decided, patients received only 75 mg clopidogrel upon presentation. Medications at discharge included aspirin for life, clopidogrel for 3--12 months in addition to statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors, when indicated. Spontaneous fibrinolysis was defined as complete ST-segment resolution concomitant to the disappearance of any chest discomfort in the few minutes upon presentation and before the initiation of any reperfusion therapy (thrombolysis or pPCI). Relevant factors associated to in-hospital death in the elderly group were studied in univariate analysis. Multivariate analysis was performed to determine factors that were independently associated to in-hospital death in the elderly group.

2.2. Statistical analysis {#sec0020}
-------------------------

Categorical variables are presented in absolute values and proportions. Continuous variables are presented as mean standard deviation as appropriate. When indicated, the Student *t*-test was used to compare means. The Pearson chi-square test was used to compare proportions between the two subgroups of the study population as a whole and in each study sub-period. It was also used to determine factors in the elderly group that were associated with in-hospital death in univariate analysis. Multivariate analysis was performed using binary logistic regression for variables that were significantly associated to in-hospital death in univariate analysis. The Hosmer and Lemeshow test was applied to discard variables that were not significantly associated with in-hospital death in the intermediate analysis. Multivariable adjusted odds ratio (OR) with accompanying 95% confidence intervals were reported. A *p* value of \<0.05 was considered statistically significant. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) 17.0 version.

3. Results {#sec0025}
==========

A total of 1403 patients were enrolled during the study period. Out of the overall study population, 1155 (82.3%) were male, 421 (30%) had arterial hypertension and 495 (35.3%) a history of diabetes mellitus. Two hundred eleven (15%) patients were part of the elderly group. Clinical characteristics and cardiovascular risk factors of the patients are presented in [Table 1](#tbl0005){ref-type="table"}. In summary, compared to younger patients, patients in the elderly group were less frequently male with a lower prevalence of tobacco smoking and obesity. Nevertheless, elderly patients were more frequently hypertensive and presented more frequently with heart failure and renal failure on-admission. New-onset atrial fibrillation and atrioventricular block in the hospital course were more frequently encountered in the elderly group. Concerning therapeutics implemented ([Table 2](#tbl0010){ref-type="table"}), thrombolysis in the acute phase of myocardial infarction was the reperfusion option in 22.3% of the cases in the elderly group compared to 36.6% in the younger group (*p* \< 0.001). Conservative medical therapy with no reperfusion treatment was chosen in 43.1% of the cases in the elderly group (vs. 28.9% in younger patients, *p* \< 0.001). The use of pPCI as the reperfusion strategy was slightly lower in the elderly group but with no statistical significance (24.2% vs. 28.8%, *p* = 0.17). No significant difference could be demonstrated in terms in reperfusion delays (either by thrombolysis or pPCI) between the two sub-groups. In-hospital mortality rate in the overall study population was at 9% and was significantly higher in the elderly group in comparison with younger patients (14.2% vs. 8.1%, *p* = 0.005). When looking at temporal trends across the four pre-specified sub-periods ([Table 3](#tbl0015){ref-type="table"}), reperfusion therapies (thrombolysis or pPCI) were numerically more used in younger patients, and in-hospital mortality remained numerically higher in the elderly subgroups except for 2002--2005 period, where it reached statistical significance. When comparing the last (2010--2013) period to the early one (1998--2001), no significant difference could be reached in in-hospital mortality and thrombolysis use between the two periods. On the other hand, a significant increase was noted in pPCI use between the early and the last period (*p* = 0.025).

Factors associated to in-hospital death in the elderly group were studied in univariate analysis ([Table 4](#tbl0020){ref-type="table"}). When compared to surviving patients (*n* = 181), those who died (*n* = 30) had more frequently heart failure and renal failure on admission (63.3% vs. 24.3%, *p* \< 0.001 and 36.7% vs. 11.6%, *p* \< 0.001, respectively). In died patients, new-onset atrial fibrillation and atrioventricular block occurred more frequently in the hospital course (26.7% vs. 9.4%, *p* = 0.019 and 33.3% vs. 13.3%, *p* = 0.006, respectively). The recourse to inotropic agents during hospital stay was more frequent in the elderly group (73.3% vs. 11%, *p* \< 0.001).

In multivariate analysis ([Table 5](#tbl0025){ref-type="table"}), the only factors that were independently associated with in-hospital death in elderly patients were heart failure on-admission (OR = 3.24, 95% CI: 1.15--9.13, *p* = 0.026), renal failure on-admission (OR = 3.67, 95% CI: 1.11--12.11, *p* = 0.033) and inotropic agents use (OR = 13.33, 95% CI: 4.78--37.03, *p* \< 0.001).

4. Discussion {#sec0030}
=============

This study is, to our knowledge, the largest published series addressing specifically the issue of STEMI in the elderly population in Tunisia. Furthermore, it presents an actual depiction of risk profile, management strategies and in-hospital prognosis of STEMI in this age group. Results are issued from a fifteen-year experience population and some of them deserve careful consideration.

Male gender preponderance in STEMI patients is maintained over age categories even though less striking in the elderly group. This finding is well explained by the difference in the risk profile between the two genders and is reported in some Middle-Eastern and larger Western studies as well.[@bib0110], [@bib0115], [@bib0120], [@bib0125] In our study, tobacco smoking as a risk factor is alarmingly prevalent. Its prevalence remains higher than that reported in other studies[@bib0110], [@bib0125] and mandate specific intervention at the population scale. Other traditional coronary risk factors are more prevalent in the elderly group except for obesity, which was less frequent in this group.

As reported in other studies,[@bib0100], [@bib0130] in our study, elderly patients presenting for STEMI are more likely to have HF upon presentation. This fact is obviously related to a higher prevalence of other HF risk factors in the elderly population such as hypertension. Likewise, elderly patients are more likely to have multivessel disease in the setting of ACS in general, a factor that is highly associated to HF in CAD both in the acute and chronic settings.[@bib0135]

Similar to that reported in others, in the present study, elderly people presenting for STEMI are more likely to be managed conservatively (i.e. with no reperfusion therapy) in comparison to younger patients. That is well accounted for by a significantly lesser recourse to thrombolysis in this population and a slight trend, although not statistically significant to less pPCI implementation. Reperfusion strategies for STEMI had been addressed in some Middle-Eastern reports.[@bib0140], [@bib0145] In the Gulf RACE registry,[@bib0140] among 8176 enrolled ACS patients, 3202 (39%) presented with STEMI; only 1584 (19%) patients underwent coronary angiography during the index hospitalization and age category failed to stand out as an independent predictor of coronary angiography use in multivariate analysis. More recently, in a 20-year analysis carried-out in Qatar, Ahmed et al.[@bib0145] reported a trend to a lesser use of thrombolysis as the reperfusion option for STEMI in the last two decades. Contrarily, pPCI prevalence increased from 2.5% to 14.6% of the overall study population and an age \>70 years arose as an independent predictor of in-hospital death. These rates are lower than those noticed in our study, where even for patients older than 75 years, pPCI was used in nearly the quarter of the cases. In the large European Euroheart Acute Coronary Syndrome survey,[@bib0100] pPCI was not the preferred reperfusion therapy in patients presenting with acute STEMI across the whole age spectrum, and a reperfusion therapy (pPCI or thrombolysis) was implemented in less than 20% of patients aged 75 years or more. More recently in the British Myocardial Ischemia National Audit Project (MINAP),[@bib0125] pPCI use in the very elderly (≥85 years) rose from 0.5% in 2003--2004 to 32.2% in 2009--2010, and use of in-hospital thrombolysis in the elderly (≥75 years) was remarkably frequent (≥50% either in men or women).

In the present study, in-hospital prognosis in elderly patients presenting with STEMI remains poor and in-hospital mortality rate is significantly higher than in younger patients. In-hospital mortality rates in patients presenting with STEMI were reported in several Middle-Eastern studies but no specific data for the elderly are available. Ahmed et al. reported a 3.6 fold higher mortality rate in patients older than 70 years when compared to those who were 50 or younger,[@bib0145] whereas in Western reports, in-hospital mortality rate across the whole age spectrum remains quite low. For example, in Scandinavian countries, where pPCI program is well established and high standards of care is applied, 30-days mortality rates in old and very old patients managed invasively was around 3%.[@bib0150], [@bib0155] Prognosis improvement in STEMI patients in Europe could be explained by the introduction of new medications in ACS improvement in clinical management in general and in the setting of pPCI in particular as well as early invasive management strategy specifically in the elderly population.[@bib0090], [@bib0160] Another explanation for the worse prognosis in STEMI patients in the present study, when compared to Western studies is the remarkable difference in cardiovascular risk profile in old Tunisian patients: prevalence of classic cardiovascular risk factors such as diabetes mellitus and hypertension in the study population is significantly higher than that reported in major Western series.[@bib0155], [@bib0165], [@bib0170]

4.1. Study limitations {#sec0035}
----------------------

This is a retrospective observational study in one Tunisian tertiary care center. Although depicting a somewhat realistic picture of STEMI management and prognosis in the elderly, data are issued from an urban population with a relatively westernized lifestyle for many of the patients enrolled. These data could not be generalized to the overall Tunisian population neither to the whole North African countries, in particular because of an important rural population in this part of the world. Contemporary therapeutic strategies are implemented only in regions benefitting from tertiary health care facilities and prognosis of old patients presenting for STEMI in far-off primary care centers with no reperfusion therapeutic option could be quite different. Likewise, the small sample size in the elderly group accounts for the lack of statistical relationship between some factors (reperfusion therapeutics, in-hospital complication) and in-hospital death. Also, the lack of precise information about all the medications at discharge taken by elderly and younger patients makes it difficult to interpret long-term outcomes in the two sub-groups. Finally, multicenter studies have to be conducted to better describe regional management and prognostic particularities and adjust intervention strategies at a nationwide scale.

5. Conclusions {#sec0040}
==============

In this single center Tunisian registry, elderly patients presenting with STEMI have a higher prevalence of cardiovascular risk factors in comparison to younger patients. Management strategies were different between the two groups with less recourse to reperfusion therapy in the elderly group. In-hospital prognosis was poor in elderly. Heart failure and renal failure on-admission as well as inotropic agents use were highly predictive of in-hospital death.
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###### 

Patients characteristics in the overall population and according to age category.

                             Population (*n* = 1403)   Age \< 75 (*n* = 1192)   Age ≥ 75 (*n* = 211)   *p*
  -------------------------- ------------------------- ------------------------ ---------------------- -------------
  Male gender                1155 (82.3%)              1011 (84.8%)             144 (68.2%)            **\<0.001**
  Hypertension               421 (30%)                 329 (27.6%)              92 (43.6%)             **\<0.001**
  Diabetes mellitus          495 (35.2%)               431 (36.2%)              64 (30.3%)             0.103
  Tobacco smoking            938 (66.8%)               842 (70.6%)              96 (45.5%)             **\<0.001**
  Obesity                    178 (12.6%)               168 (14.1%)              10 (4.8%)              **\<0.001**
  History of heart failure   33 (2.3%)                 25 (2.1%)                8 (3.8%)               0.134
  History of PCI or CABG     55 (3.9%)                 51 (4.3%)                4 (1.9%)               0.1
  Anemia                     216 (15.4%)               174 (16.1%)              42 (22.5%)             **0.033**
  Anterior localization      647 (46.1%)               553 (50.7%)              94 (49.7%)             0.8

CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.

###### 

Management of patients and in-hospital prognosis according to age category.

                                       Population (*n* = 1403)   Age \< 75 (*n* = 1192)   Age ≥ 75 (*n* = 211)   *p*
  ------------------------------------ ------------------------- ------------------------ ---------------------- -------------
  Spontaneous fibrinolysis             140 (9.9%)                125 (10.5%)              15 (7.1%)              0.131
  Conservative medical therapy         435 (31%)                 344 (28.9%)              91 (43.1%)             **\<0.001**
  Thrombolysis                         483 (34.4%)               436 (36.6%)              47 (22.3%)             **\<0.001**
  Symptoms to thrombolysis delay (h)   3.79 ± 4.03               4.2 ± 4.24               3.68 ± 2.08            0.402
  pPCI                                 394 (28%)                 343 (28.8%)              51 (24.2%)             0.17
  Symptoms to pPCI delay (h)           4.88 ± 4.23               4.9 ± 4.17               5.07 ± 4.57            0.811
  Heart failure on-admission           306 (21.8%)               243 (20.4%)              63 (29.9%)             **0.002**
  Renal failure on-admission           115 (8.2%)                83 (7%)                  32 (15.2%)             **\<0.001**
  Hyperglycemia on-admission           468 (33.3%)               401 (40.1%)              67 (36%)               0.291
  Cardiogenic shock                    33 (2.4%)                 21 (1.8%)                12 (5.7%)              **0.001**
  New onset atrial fibrillation        90 (6.4%)                 65 (5.5%)                25 (11.8%)             **\<0.001**
  Atrioventricular block               133 (9.4%)                99 (8.3%)                34 (16.1%)             **0.002**
  Hemorrhage                           38 (2.7%)                 30 (2.5%)                8 (3.9%)               0.265
  Inotropic agents use                 206 (14.6%)               164 (13.8%)              42 (19.9%)             **0.02**
  CCU length of stay (days)            4.74 ± 3.5                4.7 ± 3.46               4.98 ± 4               0.332
  In-hospital death                    127 (9%)                  97 (8.1%)                30 (14.2%)             **0.005**

CCU, coronary care unit; pPCI, primary percutaneous intervention.

###### 

Temporal trends in reperfusion therapies used and in-hospital mortality for elderly and younger patients during the study period. Percentages express rates in the corresponding age category for the indicated study period.

                                                                          1998--2001 (*n* = 281)                           2002--2005 (*n* = 349)                           2006--2009 (*n* = 382)                                                                  2010--2013 (*n* = 392)
  ----------------------- ----------------------------------------------- ------------------------------------------------ ------------------------------------------------ --------------------------------------------------------------------------------------- ------------------------
  pPCI                    Young (334)                                     19 (8.1%)                                        76 (25.2%)                                       154 (48.4%)                                                                             95 (28.1%)
  Elderly (51)            5 (11.1%)[¶](#tblfn0015){ref-type="table-fn"}   6 (12.5%)[¶](#tblfn0015){ref-type="table-fn"}    24 (37.7%)[¶](#tblfn0015){ref-type="table-fn"}   16 (29.6%)[¶](#tblfn0015){ref-type="table-fn"}^,^[£](#tblfn0010){ref-type="table-fn"}   
  Thrombolysis            Young (436)                                     107 (45.3%)                                      130 (43.2%)                                      60 (18.9%)                                                                              139 (41.1%)
  Elderly (47)            12 (26.7%)                                      14 (29.2%)[¶](#tblfn0015){ref-type="table-fn"}   6 (9.4%)[¶](#tblfn0015){ref-type="table-fn"}     15 (27.8%)[¶](#tblfn0015){ref-type="table-fn"}^,^[∞](#tblfn0020){ref-type="table-fn"}   
  In-hospital mortality   Young (97)                                      11 (4.7%)                                        26 (8.6%)                                        28 (8.8%)                                                                               33 (9.8%)
  Elderly (30)            4 (8.9%)[¶](#tblfn0015){ref-type="table-fn"}    12 (25%)[\*](#tblfn0005){ref-type="table-fn"}    7 (10.9%)[¶](#tblfn0015){ref-type="table-fn"}    7 (13%)[¶](#tblfn0015){ref-type="table-fn"}^,^[∞](#tblfn0020){ref-type="table-fn"}      

pPCI, primary percutaneous coronary intervention.

*p* = 0.001 vs. in younger patients for the same period.

*p* = 0.025 vs. in elderly patients for 1998--2001 period.

*p* non-significant vs. in younger patients for the same period.

*p* non-significant vs. in elderly patients for 1998--2001 period.

###### 

Factors associated to in-hospital death in elderly patients in univariate analysis.

                                       Surviving (*n* = 181)   Dead (*n* = 30)   *p*
  ------------------------------------ ----------------------- ----------------- -------------
  Female gender                        53 (29.3%)              14 (46.7%)        0.058
  Hypertension                         77 (42.5%)              15 (50%)          0.44
  Diabetes mellitus                    51 (28.2%)              13 (43.3%)        0.09
  Obesity                              9 (5%)                  1 (3.3%)          0.69
  History of CAD                       17 (9.4%)               3 (10%)           0.31
  History of heart failure             7 (3.9%)                1 (3.3%)          0.88
  Heart failure on-admission           44 (24.3%)              19 (63.3%)        **\<0.001**
  Anterior localization                77 (48.1%)              17 (58.6%)        0.29
  Spontaneous fibrinolysis             14 (7.7%)               1 (3.3%)          0.385
  Conservative medical therapy         74 (40.9%)              17 (56.7%)        0.211
  Thrombolysis                         42 (23.2%)              5 (16.7%)         0.425
  Symptoms to thrombolysis delay (h)   3.66 ± 2.1              3.8 ± 2.16        0.894
  Primary PCI                          43 (23.8%)              8 (26.7%)         0.581
  Symptoms to pPCI delay (h)           5.15 ± 4.84             4.63 ± 2.92       0.769
  Anemia                               126 (79.7%)             19 (65.5%)        0.091
  Renal failure on-admission           21 (11.6%)              11 (36.7%)        **\<0.001**
  Hyperglycemia on-admission           50 (31.8%)              17 (58.6%)        **0.006**
  Cardiogenic shock                    5 (2.8%)                7 (23.3%)         **\<0.001**
  New onset atrial fibrillation        17 (9.4%)               8 (26.7%)         **0.019**
  Atrioventricular block               24 (13.3%)              10 (33.3%)        **0.006**
  Hemorrhage                           5 (2.9%)                3 (10%)           0.063
  Inotropic agents use                 20 (11%)                22 (73.3%)        **\<0.001**

###### 

Factors independently associated to in-hospital death in elderly patients in multivariate analysis.

  Variable                     Odds ratio   95% CI        *p*
  ---------------------------- ------------ ------------- ---------
  Hyperglycemia on-admission   2.67         0.97--7.38    0.057
  Heart failure on-admission   3.2          1.15--9.13    0.026
  Renal failure on-admission   3.6          1.11--12.11   0.033
  Inotropic agents use         13.3         4.78--37.03   \<0.001
